UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C.   20549


                                 FORM 10-QSB
                 Quarterly Report Under Section 13 or 15(d)
                   of the Securities Exchange Act of 1934.


For the quarter ended  June 30, 2000    Commission file number   000-25523




                         ANONYMOUS DATA CORPORATION
           (Exact name of registrant as specified in its charter)



Nevada                                                 86-0857752
(State or other jurisdiction of                        (I.R.S. Employer
incorporation or organization)                         Identification No.)

6170 W. Desert Inn
Las Vegas, Nevada                                      89146
(Address of principal executive offices)               (Zip Code)


                               (702) 221-0756
             Registrant's telephone number, including area code


     Indicate by check mark whether the registrant (1) has filed all  reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934  during  the  preceding 12 months (or for such shorter period  that  the
registrant  was required to file such reports), and (2) has been  subject  to
such filing requirements for the past 90 days.

                             Yes     X       No


      As of June 30, 2000, there were 11,530,660 shares of common stock
                                outstanding.
<PAGE>

                         ANONYMOUS DATA CORPORATION
                            FOR THE QUARTER ENDED
                                JUNE 30, 2000

                                    INDEX

PART I - FINANCIAL INFORMATION                              Page No.

     Item 1.   Financial Statements

               Balance Sheets as of June 30, 2000
               and December 31, 1999                                   3

               Income Statements for the three-month periods
               ended June 30, 2000 and June 30, 1999                   4

               Income Statements for the six-month periods
               ended June 30, 2000 and June 30, 1999                   5

               Statement of Stockholders' Equity
               for the six months ended June 30, 2000                  6

               Statements of Cash Flow for the six-month
               periods ended June 30, 2000 and June 30, 1999           7

     Item 2.   Management's Discussion and Analysis of
               Financial Condition and Results of Operation            8-12

PART II - OTHER INFORMATION

     Item 1.   Legal Proceedings                                       13

     Item 2.   Changes in Securities                                   13

     Item 3.   Defaults by the Company upon its
               Senior Securities                                       13

     Item 4.   Submission of Matter to a Vote of
               Security Holders                                        13

     Item 5.   Other Information                                       13

     Item 6.   Exhibits and Reports of Form 8-K                        13

     SIGNATURES                                                        14
<PAGE>
<TABLE>
                         ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                               BALANCE SHEETS

                       PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
                              ASSETS
                                        June 30, 2000       December 31, 1999
                                           (unaudited)
<S>                                     <C>              <C>
Current assets:
  Cash                                       $   12,982          $  3,939
  Prepaid expenses                              445,569
                                        --------------      -------------
                                                458,551             3,939

 Furniture, fixtures and equipment              160,554           125,449
 Less accumulated depreciation                  (49,455)          (36,224)
                                        ----------------    -------------
                                                111,099            89,225

Unamortized patent costs                        103,979            96,038
                                   -------------------      -------------
                                               $673,629          $189,202
                                      ================      ===============
</TABLE>
<TABLE>

                    LIABILITIES AND STOCKHOLDERS' EQUITY
<S>                                      <C>               <C>
Current liabilities:
 Accounts payable                           $     1,908          $ 37,569
 Payroll taxes payable                            7,089             7,089
 Accrued interest, officer                       13,500             5,100
 Other                                                              1,528
                                       ---------------      -------------
                                                 22,497            51,286
Long-term debt, officer                         240,500            51,000
                                       ----------------     -------------
Total liabilities                               262,997           102,286
                                       ----------------     -------------
Stockholders' equity:
 Common stock, $.001 par,
 100,000,000 shares
 authorized, 11,530,660
 shares issued and outstanding                  11,531             9,438

 Preferred stock, $.001 par, 25,000,000
 Shares authorized, none issued
 and outstanding

 Additional paid-in capital                  4,738,664         1,692,376

 Deficit accumulated during development
 stage                                      (4,339,563)       (1,614,898)
                                       ---------------      ------------
                                               410,632            86,916
                                       ---------------      ------------
                                              $673,629          $189,202
                                       ===============      ============
</TABLE>
                     See notes to financial statements.
<PAGE>
<TABLE>

                         ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                              INCOME STATEMENTS
FOR THE THREE MONTH PERIODS ENDED JUNE 30, 2000 AND JUNE 30, 1999 (unaudited)


                                               2000                 1999
<S>                                     <C>                     <C>
Operating costs and expenses:

  Research and development               $    201,352             $  23,828

  Administrative                               21,339               139,821

  Depreciation                                 13,231

  Interest                                      8,574
                                        -------------          ------------
                                              244,496               163,649
                                        --------------         ------------

Income, other                                      --                 5,668
                                        --------------         ------------
Net loss                                 $   (244,496)            $(157,981)
                                        --------------         -------------

Loss per share                                  (0.02)                (0.02)
                                        =============          ============
Weighted average of number of shares
outstanding                                10,786,374             9,413,160
                                        =============          ============
</TABLE>
See notes to financial statements.
<PAGE>
<TABLE>
            ANONYMOUS DATA CORPORATION ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                              INCOME STATEMENTS
 FOR THE SIX MONTH PERIODS ENDED JUNE 30, 2000 AND JUNE 30, 1999 (unaudited)


                                               2001            1999
<S>                                     <C>                 <C>
Operating costs and expenses:

  Research and development              $2,606,481           $228,394

  Administrative                            98,854            488,360

  Depreciation                              13,231

  Interest                                   8,574
                                      ------------          ---------
                                        $2,727,140           $716,754
                                      ------------          ---------

Income, other                                2,475              7,177
                                      ------------          ---------
Net loss                               $(2,724,665)        $(709,577)
                                      ------------          ---------

Loss per share                               (0.03)            (0.08)
                                      ============         ==========
Weighted average of number
of shares outstanding                   10,786,374          9,222,360
                                      ============         ==========
</TABLE>
See notes to financial statements.
<PAGE>
<TABLE>
                         ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)
                   FOR THE SIX MONTHS ENDING JUNE 30, 2000


                         Common Stock       Additional    Accumulated
                        Shares  Par Value Paid-In Capital  Deficit    Total
                    -----------   ------  -----------  -----------   --------
<S>                <C>          <C>      <C>          <C>           <C>
Balance 12-31-99      9,438,160   $9,438   $1,692,376  $(1,614,898)  $86,916
Shares issued to
  consultants for
  services            2,092,500    2,093    3,046,288              3,048,381
 Net loss                                              (2,724,665)(2,724,665)
                    -----------   -------  ----------  ----------  ---------
Balance 6-30-00      11,530,660   $11,531  $4,738,664 $(4,339,563)  $410,632
                     ========== =========  ==========  ==========   ========
</TABLE>
See notes to financial statements.
<PAGE>
<TABLE>
                         ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                          STATEMENTS OF CASH FLOWS
       FOR THE SIX MONTH PERIODS ENDED JUNE 30, 2000 AND JUNE 30, 1999

                                              2000                  1999
                                           (unaudited)
                                       <C>                      <C>
Operating activities:

  Net loss                              $ (2,724,665)            $(709,577)

  Expenses reimbursed with stock           3,048,381               376,210

  Depreciation                                13,231

  Change in operating assets:

  Increase in other assets                                          (2,750)

  Increase in prepaid expenses             (445,569)

  Change in operating liabilities:

  Decrease in accounts payable              (35,661)

  Increase in accrued interest                8,400
                                        ------------         --------------
Net cash used by operating activities      (135,883)              (336,117)
                                        ------------         --------------
Investing activities:

  Purchase of equipment                     (35,105)                (9,741)

  Patent costs                               (7,941)               (23,465)

  Deferred offering costs                                           144,000
                                        -----------           -------------
  Net cash used in investing activities     (43,046)                110,794
                                        ------------          -------------
Financing activities:

  Payments on lease purchase obligation      (1,528)                (3,928)

  Sale of common stock                      365,250

  Loan from principal shareholder           189,500
                                        -----------           -------------
  Net cash provided by financing
  activities                                187,972                 361,322
                                        -----------           -------------
Net increase in cash                          9,043                 135,999

Cash, beginning                               3,939                  13,793
                                        -----------           -------------
Cash, ending                                 12,982                 149,792
                                        ===========           =============
</TABLE>
                     See notes to financial statements.
<PAGE>
                         ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                        NOTES TO FINANCIAL STATEMENTS

1.   Summary of significant accounting policies:

Nature  of  business.   The Company is a development stage  enterprise  and,
therefore, as of June 30, 2000, has not commenced business operations.   The
Company  was  incorporated in 1996, for the purpose of developing  biometric
equipment  and  related  software to store  and  retrieve  data  of  medical
laboratory testing.  The Company is in the research and development phase of
testing  its  technical  equipment  and  software.   The  Company's   future
operations  could  be  affected by adverse changes  in  local  and  national
economic conditions.  (See Note 3.)

Basis  of  presentation.  The accompanying unaudited consolidated  financial
statements  have  been  prepared  in  accordance  with  generally   accepted
accounting principles for interim financial information and the instructions
to  Form  10-Q and Rule 10-01 of Regulation S-X.  Accordingly, they  do  not
include  all  of  the  information  and disclosures  required  by  generally
accepted  accounting  principles for annual financial  statements.   In  the
opinion  of management, all adjustments (consisting only of normal recurring
adjustments)  considered  necessary  for  a  fair  presentation  have   been
included.   The  results  of  operations for  any  interim  period  are  not
necessarily  indicative  of  results for the full  year.   These  statements
should  be  read  in conjunction with the financial statements  and  related
notes,  that  appear in the Company's Annual Report on Form 10-KSB  for  the
period  ended  December 31, 1999.  The balance sheet at June 30,  2000,  was
derived from the audited financial statements included in that report.

Offering  costs.  The Company has offered its unregistered common  stock  to
the  public  in offerings intended to be exempt from registration  with  the
United States Securities and Exchange Commission (SEC) pursuant to Rule  504
promulgated  under the Securities Act of 1933.  The costs of  the  offerings
have been offset against the proceeds to date.

Use  of estimates.  Timely preparation of financial statements in conformity
with  generally accepted accounting principles requires management  to  make
estimates and assumptions that affect reported amounts and disclosures, some
of which may require revision in future proceeds.

Equipment,  depreciation and amortization.  Equipment  is  stated  at  cost.
Depreciation and amortization is provided by an accelerated method over  the
estimated useful live of the assets.

Stock  compensation  awards.  The company has adopted  Financial  Accounting
Standard  Board  Statement No. 123 Accounting for Stock-Based  Compensation,
for valuing compensatory stock and option awards.  (See Note 5.)

Patent costs.  Cost associated with patents and patents pending are deferred
and  amortized based on the lives of patents granted.  In the  event  patent
applications  are  denied or abandoned, such costs  are  written  off.   For
patents granted late in the year, amortization begins in the following year.
<PAGE>

                         ANONYMOUS DATA CORPORATION
                      (A Development Stage Enterprise)
                  NOTES TO FINANCIAL STATEMENTS (CONTINUED)


1.      Summary of significant accounting policies (Continued):

Loss  per  share.  Loss per share is computed based on the weighted  average
number of shares outstanding for the periods presented.

2.   Related party transactions:

Dr.  James  E.  Beecham  (Chairman of the Board of  Directors  and  majority
shareholder  and president of the Company) has licensed to the  Company  the
rights  associated  with  two  U.S.  patents  pending.   The  licenses   are
irrevocable until May 14, 2008.  Dr. Beecham has also agreed to  extend  the
licenses  for  an  additional eight years depending  upon  performance.   In
consideration  for  the  assignment of rights, Dr. Beecham  will  receive  a
royalty of 3% of the first $10 million, 2% of $10 to $25 million, and 1%  in
excess of $25 million in gross revenues to the Company from the manufacture,
use, sale or operation of the products and services.

The  Chairman has loaned the Company during the three months ended March 31,
2000,  $92,500  at  10% annually.  Interest payments are due  annually  with
principal balance due in its entirety at the five year maturity date.

During  early  1999, the Company issued 129,500 shares of its  common  stock
valued at $1 per share to its officers/directors as compensation.

3.   Common stock issuances:

      For  the  current  period,  the Company issued  2,092,500  shares  for
services.  Of  these 1,720,000 shares previously registered using  Form  S-8
were  issued  to  employees under established stock based  employee  benefit
programs. Accordingly, these shares were valued at market value on the  date
of  grant.  The Company also issued 372,500 restricted shares to others  for
services  pursuant to Rule 144, which were valued based on the market  value
of  the  term  of  grant, less a 15% discount.  Of those  shares  issued  to
employees, 550,000 shares were issued for future services.  Of those  shares
issued  under  Rule  144,  35,000 shares were issued  for  future  services.
Prepaid expenses represents the unamortized portion of future services to be
rendered through January 31, 2001, and is a result of these grants.
<PAGE>

4.   Going concern contingency:

The  Company's ability to complete certain research projects and development
of  its  equipment  and  software development is  dependent  upon  obtaining
additional  equity  or  debt financing.  This condition  could  prevent  the
Company  from  commencing  business operations and  continuing  as  a  going
concern.  The balance sheet, however, has been prepared assuming the Company
will  continue as a going concern, and it reflects no adjustments that might
result  from  the  outcome of this uncertainty.  However,  because  of  this
uncertainty,  no effect has been given in the balance sheet  to  any  future
income  tax  benefit of the loss recorded to date.  The Company  has  a  net
operating  loss carryforward as of December 31, 1999, expiring in year  2019
available to reduce future income tax expense in the amount of approximately
$1,600,000.

Management expects to raise additional equity capital by offering its common
stock  for  sale  to investors through private placement or by  registration
with  the  SEC under the Securities Act of 1933 or obtain debt financing  to
complete  its  research  projects  and  equipment  and  obtain  the  related
additional  patents.   Management expects that the  Company's  medical  data
management equipment, when completed, will have a wide range of applications
in  medical  testing  data  storage.  Management's  ability  to  effectively
implement  its  plans  could have a material and  adverse  effect  upon  the
Company's business, financial condition and future operations.

5.      Subsequent event:

Subsequent to June 30, 2000, the Company issued 310,500 shares of registered
common  stock  as  compensation to employees  including  300,000  shares  to
directors.

<PAGE>

Item 2.   Management's Discussion and Analysis of Financial Condition and
Results of Operations.

      The  following  discussion and analysis should be read in  conjunction
with  the  Company's  financial statements and the notes  thereto  contained
elsewhere in this filing.

Overview

     Anonymous  Data  Corporation, a Nevada corporation  (the  "Company"  or
"ADC") formed in November 1996, is a development stage enterprise engaged in
the business of data management using a biometric identification system. The
biometric  identification  system; (i) archives  individual  data,  such  as
medical  educational  information, for access by  registered  users  through
rapid  sorting using scanning of a portion of their anatomy as a preliminary
search  method;  and,  (ii)  permits a second method  of  identification  of
individuals volunteering for payment as plasma donors.

Background

     We  have obtained rights to a method of linking files of archived  data
to the anatomy of an individual.  This method allows the search function for
records  to be more rapid and accurate and re-checked according to the  name
of  the  individual. We have spent $281,438 during 1999 toward research  and
development   toward  the  refinement  of  our  biometric  individual   data
identification system.

     The  term  BIOMETRIC derives from the words body (BIO) and  measurement
(METRIC).  The  science  of  biometrics has in recent  years  developed  the
technology  to  take a reading from a human (such as electronic  scan  of  a
fingerprint, iris scan, facial recognition, palm print, voice sample,  etc).
The  electronic  scan  is then matched with the same  biometric  marker  for
purposes  of  recognition and verification of identity.  The  United  States
Patent  and  Trademark Office has issued two U.S. patents to  Dr.  James  E.
Beecham, Chairman of the Company. The Patents, Patent Numbers U.S. 5,876,926
[PCT/U.S.  98/16435]) and U.S. 5,897,989 [PCT/U.S. 97/08015], pertain  to  a
method,  system  and apparatus that permit an individual to submit  biologic
test  specimens  for  medical  testing under biometric  identification.  The
system  then  allows  for the subsequent retrieval of test  results  from  a
computerized  database utilizing the same biometric personal identification.
These  Patents have been exclusively licensed to us from Dr. Beecham. -  See
"Certain Transactions - License Agreement."

     The  patented applications, in non-U.S. territories, will  be  utilized
for collecting medical specimens in containers labeled by "biometric index".
For  example,  a  biometric  index  may be  obtained  from  the  scan  of  a
fingerprint  and/or the scan of the iris of the eye of the  specimen  donor.
After   testing  in  a  certified  laboratory,  the  test  data  is   stored
electronically under linkage to that same personal biometric  index.  Access
to  such "biometrically" stored information is controlled by the re-scan  of
the specimen donor. Since viewing the data requires "unlocking" the computer
file by scanning the same fingerprint and/or eye as was used for sending the
specimen  to  the  lab  in the first place, our system provides  the  secure
protection of the donors sample and limits mistakes that are sometimes  made
in the donation process.

<PAGE>

     We  have developed a plan and are in the process of developing a method
for  providing services and products worldwide based on our exclusive patent
licenses.  We plan to offer these products as turnkey systems  and  also  to
offer services directly to subscribers domestically and abroad.

Results  of Operations for the three and six months ended June 30, 2000  and
June 30, 1999
(unaudited)

     Total  operating expenses from continuing operations were $244,496  for
the  three  months ended June 30, 2000 compared to $163,649  for  the  three
months  ended June 30, 1999.  Operating expenses for the three months  ended
June  30,  2000  includes $201,351 expense related to the value  of  Company
shares  issued  to  consultants for services.  Utilizing  an  average  daily
calculation of operating expenses of $2,687 for the period ending  June  30,
2000,  and an average daily calculation of operating expenses of $1,798  for
the  period ending June 30, 1999, this represented a 49% increase in average
daily operating expenses.
     Total operating expenses from continuing operations were $2,727,140 for
the  six months ended June 30, 2000, compared to $716,754 for the six months
ended  June 30, 1999.  Operating expenses for the six months ended June  30,
2000,  includes  $2,603,348 expense related to the value of  company  shares
issued  to consultants for services.  Utilizing an average daily calculation
of operating expenses of $14,984 for the period ending June 30, 2000, and an
average  daily  calculation of operating expenses of $3,960 for  the  period
ending  June  30,  1999, this represents a 253% increase  in  average  daily
operating expenses.

Forward-Looking Statements and Associated Risks

     This   Quarterly   Report  on  Form  10-QSB  contains   forward-looking
statements  made  pursuant to the safe harbor provisions of  the  Securities
Litigation Reform Act of 1995.  These forward looking statements  are  based
largely  on the Company's expectations and are subject to a number of  risks
and   uncertainties,  many  of  which  are  beyond  the  Company's  control,
including,  but  not  limited to, economic, competitive  and  other  factors
affecting   the  Company's  operations,  markets,  products  and   services,
expansion  strategies and other factors discussed elsewhere in  this  report
and  the  documents  filed by the Company with the Securities  and  Exchange
Commission.   Actual  results could differ materially  from  these  forward-
looking statements.  In light of these risks and uncertainties, there can be
no  assurance that the forward-looking information contained in this  report
will  in fact prove accurate.  The Company does not undertake any obligation
to  revise  these  forward-looking statements to reflect  future  events  or
circumstances.

Liquidity and Capital Reserves

As of June 30, 2000 and June 30, 1999 (Unaudited)

     As  of  June  30,  2000,  the Company's assets were  $673,629  and  its
liabilities were $262,997, resulting in an excess of assets of $410,632. The
assets  include  prepaid expenses of $445,569 representing  the  unamortized
portion  of  future  services to be rendered through  January  31,  2001  by
consultants who received the Company's common shares for such service.  Cash
was  $12,982  at June 30, 2000 as compared to cash of $149,792 on  June  30,
1999,  a  decrease of $136,810. This represented a 91% decrease in available
cash.  This  decrease was primarily the result of an increase  in  operating
expenses.
<PAGE>

     The  Company  has continued to fund its deficit cash flow from  private
placements of the Company's common stock. It is anticipated that  loans  and
the sale of the Company's stock will continue until such time as the Company
generates  sufficient  revenues  from  its  operations  to  cover  operating
expenses.
PART II--OTHER INFORMATION

Item 1.       Legal Proceedings.

     The  Company recently settled a suit filed on January 14, 2000 by  Asia
Pacific, Inc., a Nevada Corporation, dba Laser Barcode Solutions, which  was
filed  in  District  Court  in  Clark County, Nevada,  Case  Number  A413603
Department  XII  against Anonymous Data Corporation and the President  James
Beecham  claiming  Breach  of  Contract, Tortious  Breach  of  Contract  and
Negligent/Intentional Misrepresentation.

Item 2.       Changes in Securities.

     None.

Item 3.       Defaults by the Company upon its Senior Securities.

     None.
Item 4.       Submission of Matter to a Vote of Security Holders.

     None

Item 5.       Other Information.

     None

Item 6.       Exhibits and Reports of Form 8--K.

     None
<PAGE>

                                 SIGNATURES


     Pursuant  to the requirements of the Securities Exchange Act  of  1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


ANONYMOUS DATA CORPORATION
(Registrant)



By:/s/ James E. Beecham
    James E. Beecham
     President

Date: August 11, 2000